A Mouse for Every Gene

The National Institutes of Health has awarded a five-year cooperative agreement worth approximately $23 million to a consortium of the Children's Hospital Oakland Research Institute; UC Davis; and the Wellcome Trust Sanger Institute, England.

The group plans to create lines of embryonic mouse stem cells in which 5,000 individual genes will be systematically turned off, or "knocked out." Those embryonic stem cells will then be used to breed live mice that lack those genes.

"This award places UC Davis and its School of Veterinary Medicine front and center as a resource for genetically altered mice," said Bennie Osburn, dean of the school. "Our understanding of animal and human disease will progress more quickly as these essential mouse models become more available to scientists."

The UC Davis Mouse Biology Program was established in 1997 to support and expand research by campus scientists using genetically altered mice. The program is already the largest of the major sites in the NIH-funded Mutant Mouse Regional Resource Centers network, where researchers can deposit gene-modified mice that they have created and request specific mice for noncommercial research purposes.

Scientists have been making knockout mice since 1988, but so far these cover only about 5,000 genes, or about 25 percent of the mouse genome, said Kent Lloyd, a principal investigator on the grant and associate dean for research at the School of Veterinary Medicine.

"The technology is now here to do this on a high-throughput basis," Lloyd said. "Within five years, through this and related projects around the world, scientists will have access to knockouts of the whole mouse genome."

Ten thousand genes that are most closely shared between mice and humans are a high priority for the NIH. Studying how those genes work in mice can give insights into human health and disease.

Scientists at Children's Hospital Oakland Research Institute will make the altered DNA for the mice; researchers at the Sanger Institute will insert that DNA into mouse embryonic stem cells; and UC Davis scientists will use those cells to breed the mice and check that the correct genes are knocked out.

The mice created by the NIH program will be available to other researchers through a public repository, which will be funded under a separate grant from NIH.

In addition to Lloyd, the leaders of the consortium are Pieter deJong of Children's Hospital, and Allan Bradley and William Skarnes at the Sanger Institute.

The grant is one of several announced by the NIH Sept. 7 to launch the Knockout Mouse Project. The others include a second, complementary grant to generate knockout mice, and smaller grants for a data coordination center and research on improving methods for making gene-altered mice.

Source: University of California, Davis

Thumbs up -- a tiny ancestral remnant lends developmental edge to humans
Subtle genetic changes that confer an evolutionary advantage upon a species, such as the dexterity characteristic of the human hand, while difficult to detect and even harder to reproduce in a model system, have nevertheless generated keen interest amongst evolutionary biologists. In findings published online in the September 5 edition of the journal Science, researchers from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and their collaborators, have uncovered a specifically human 13-nucelotide change concealed in the vast three-billion-letter landscape of the human genome.
Scientists identify genetic link that may neutralize HIV
Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This new information will likely spur a new approach for making an HIV vaccine that elicits neutralizing antibodies. Neutralizing antibodies, once produced in the host, can attack and checkmate an infecting virus. The research was reported in the September 5 issue of Science.
You can be replaced: Immune cells compensate for defective DNA repair factor
A new mouse model has provided some surprising insight into XLF, a molecule that helps to repair lethal DNA damage. The research, published by Cell Press in the September 5th issue of the journal Molecular Cell, suggests that although XLF shares many properties with well known DNA repair factors, certain cells of the immune system possess an unexpected compensatory mechanism that that can take over for nonfunctional XLF.
Researchers offer first direct proof of how osteoarthritis destroys cartilage
A team of orthopaedic researchers has found definitive, genetic proof of how the most common form of arthritis destroys joint cartilage in nearly 21 million aging Americans, according to a study published online Sept. 2 in the Journal of Bone and Mineral Research. The findings serve as an important foundation for the design of new treatments for osteoarthritis (OA), researchers said.
Joslin study identifies protein that produces 'good' fat
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.
New research suggests diabetes transmitted from parents to children
A new study in the September issue of the Journal of Lipid Research suggests an unusual form of inheritance may have a role in the rising rate of diabetes, especially in children and young adults, in the United States.
Chemical liberated by leaky gut may allow HIV to infect the brain
In up to 20 percent of people infected with HIV, the virus manages to escape from the bloodstream and cross into the brain, resulting in HIV-associated dementia and other cognitive disorders. Now, scientists at the Albert Einstein College of Medicine of Yeshiva University have found strong evidence that a component of the cell walls of intestinal bacteria—a chemical present in high levels in the blood of HIV-infected people—helps HIV to penetrate the usually-impregnable blood brain barrier (BBB). The findings, published in the August issue of the Journal of Virology, could lead to strategies for preventing HIV from entering the brain and causing serious complications.
Key to Treating Cancer May Be Finding its Original Cell
(PhysOrg.com) -- Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.

A Mouse for Every Gene

Related stories:

News discussion: